Sonoma Pharmaceuticals (SNOA) Revenue Growth (1y) (2011 - 2026)
Sonoma Pharmaceuticals (SNOA) Revenue Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn | 2.34% |
| 3 | Zoetis | 32.57 Bn | 30.63 Bn | 1.62 Bn | 2.91% |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn | -11.85% |
| 5 | United Therapeutics | 23.08 Bn | 20.93 Bn | 648.10 Mn | -1.62% |
| 6 | RedHill Biopharma | 22.43 Bn | 22.43 Bn | - | - |
| 7 | Viatris | 20.23 Bn | 18.42 Bn | 1.16 Bn | 7.85% |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.46 Bn | 800.70 Mn | 42.25% |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn | 14.92% |
| 10 | Sonoma Pharmaceuticals | 1.97 Mn | -430,067.30 | 2.18 Mn | 48.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48.14% |
| Dec 31, 2025 | 22.03% |
| Sep 30, 2025 | 56.58% |
| Jun 30, 2025 | 18.40% |
| Mar 31, 2025 | 9.16% |
| Dec 31, 2024 | 13.58% |
| Sep 30, 2024 | 31.05% |
| Jun 30, 2024 | -1.05% |
| Mar 31, 2024 | 14.10% |
| Dec 31, 2023 | 6.59% |
| Sep 30, 2023 | -18.01% |
| Jun 30, 2023 | -13.96% |
| Mar 31, 2023 | 31.16% |
| Dec 31, 2022 | 1.45% |
| Sep 30, 2022 | -11.03% |
| Jun 30, 2022 | 8.12% |
| Mar 31, 2022 | 6.54% |
| Dec 31, 2021 | -41.21% |
| Sep 30, 2021 | -35.10% |
| Jun 30, 2021 | -36.12% |